Kymera Therapeutics Inc (KYMR)
24.16 -2.20 (-8.35%) 15:44 ET [NASDAQ]
23.98 x 200 24.11 x 500
Realtime by (Cboe BZX)
23.98 x 200 24.11 x 500
Realtime 24.61 -1.75 (-6.64%) 09:30 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | KYMR | ARWR | APGE | ||
| Company | Kymera Therapeutics Inc | Arrowhead Pharma | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.64 | 12.13 | 36.22 | ||
| High | 25.07 | 12.36 | 36.74 | ||
| Low | 23.98 | 11.60 | 33.58 | ||
| Last | 24.16 | 12.15 | 35.07 | ||
| Change | -2.20 | -0.54 | -2.76 | ||
| % Change | -8.35% | -4.26% | -7.30% | ||
| Volume | 404,067 | 1,732,466 | 467,504 | ||
| 20-Day Average Volume | 628,875 | 1,696,188 | 754,580 | ||
| Previous Close | 26.36 | 12.69 | 37.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.47 | 14.55 | 38.83 | ||
| 20-Day Raw Stochastic | 4.94% | 8.86% | 21.11% | ||
| 20-Day Relative Strength | 30.31% | 30.92% | 44.18% | ||
| Weighted Alpha | -52.79 | -66.11 | -40.10 | ||
| Today's Opinion | 100% Sell | 100% Sell | 80% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 64% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -18.71% since 03/27/25 | -12.10% since 03/27/25 | -9.99% since 03/27/25 | ||
| Low | 23.98 on 04/03/25 | 11.60 on 04/03/25 | 33.58 on 04/03/25 | ||
| High | 30.42 on 03/28/25 | 13.99 on 03/28/25 | 39.93 on 03/28/25 | ||
| 1-Month | |||||
| %Chg | -18.63% since 03/03/25 | -31.51% since 03/03/25 | +12.55% since 03/03/25 | ||
| Low | 23.98 on 04/03/25 | 11.60 on 04/03/25 | 29.10 on 03/04/25 | ||
| High | 35.51 on 03/13/25 | 17.79 on 03/06/25 | 41.87 on 03/12/25 | ||
| 3-Month | |||||
| %Chg | -40.97% since 01/03/25 | -38.71% since 01/03/25 | -26.04% since 01/03/25 | ||
| Low | 23.98 on 04/03/25 | 11.60 on 04/03/25 | 29.10 on 03/04/25 | ||
| High | 45.31 on 01/27/25 | 21.84 on 02/07/25 | 50.56 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | -43.45% since 10/03/24 | -35.65% since 10/03/24 | -37.85% since 10/03/24 | ||
| Low | 23.98 on 04/03/25 | 11.60 on 04/03/25 | 29.10 on 03/04/25 | ||
| High | 53.23 on 11/11/24 | 27.34 on 11/29/24 | 63.50 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,711,924 | 1,742,553 | 1,703,372 | ||
| Shares Outstanding, K | 64,944 | 137,317 | 45,027 | ||
| Annual Sales | 47,070,000 | 3,550,000 | 0 | ||
| Annual Net Income | -223,860,000 | -599,490,000 | -182,150,000 | ||
| Last Quarter Sales | 7,390,000 | 2,500,000 | 0 | ||
| Last Quarter Net Income | -70,750,000 | -173,090,000 | -67,220,000 | ||
| 60-Month Beta | 2.22 | 0.99 | 1.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.88 on 02/27/25 | -1.39 on 02/10/25 | -1.19 on 03/03/25 | ||
| Latest Earnings Date | 05/01/25 | 05/08/25 | 05/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||